OKYO – okyo pharma limited - ordinary shares (US:NASDAQ)
Stock Stats
News
OKYO Pharma to present first-in-human urcosimod data at ARVO 2026 [Yahoo! Finance]
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
OKYO Pharma (NASDAQ:OKYO) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
OKYO Pharma (NASDAQ:OKYO) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
OKYO Pharma has analysts bullish as FDA endorses Phase 2b/3 trial in neuropathic corneal pain [Yahoo! Finance]
Form 6-K OKYO Pharma Ltd For: Feb 23
Form SCHEDULE 13G OKYO Pharma Ltd Filed by: Point72 Asset Management, L.P.
Form 424B5 OKYO Pharma Ltd
Form SCHEDULE 13G/A OKYO Pharma Ltd Filed by: Chernett Jorey
Form 6-K OKYO Pharma Ltd For: Feb 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.